Home › NCT02055105

Modulation of Molecular Fingerprinting in Pediatric Sepsis

Who can join

Ages 1 to 18 · All sexes

Inclusion Criteria:

* Age 1 through 18 years
* Patients admitted to the PICU with concerns for sepsis or those developing sepsis during their admission to the hospital.
* Patients must be enrolled int he study from arrival time tot he ED up to 24 hours from the time of initiation of antibiotic therapy for treatment of sepsis or septic shock.
* Signed informed consent.

Exclusion Criteria:

* Patients \<1 year of age and greater than 18 years of age.

About the study

The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.

What is being tested

• miRNA in Sepsis (procedure)

Sponsor: Phoenix Children's Hospital · Participants: 50 · Started: 2014-03

Contact the study team

• Frederick A Willyerd, MD · Phone: 6029331784
• Althaia Calla G Ignacio, BSN, MD · Phone: 6029333795

Official record on ClinicalTrials.gov — NCT02055105

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.